Format

Send to

Choose Destination
Nat Chem Biol. 2013 Dec;9(12):785-7. doi: 10.1038/nchembio.1359. Epub 2013 Oct 6.

Development of small-molecule inhibitors targeting adipose triglyceride lipase.

Author information

1
Institute of Organic Chemistry, Graz University of Technology, 8010 Graz, Austria.
2
Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
3
Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.
4
Novo Nordisk A/S, Novo Nordisk Park, DK-2760 Måløv, Denmark.
#
Contributed equally

Abstract

Adipose triglyceride lipase (ATGL) is rate limiting in the mobilization of fatty acids from cellular triglyceride stores. This central role in lipolysis marks ATGL as an interesting pharmacological target as deregulated fatty acid metabolism is closely linked to dyslipidemic and metabolic disorders. Here we report on the development and characterization of a small-molecule inhibitor of ATGL. Atglistatin is selective for ATGL and reduces fatty acid mobilization in vitro and in vivo.

PMID:
24096302
PMCID:
PMC3829776
DOI:
10.1038/nchembio.1359
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center